Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
NCT00108446 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2009-01-21
Summary
This study is being done to collect new information on irritable bowel syndrome, a disease that causes abdominal pain that does get better with treatment or keeps coming back ("chronic"). To better understand what causes the irritable bowel syndrome, we are studying drugs used to treat pain, dextromethorphan, naloxone, fentanyl, and lidocaine. We will study the effects these drugs have on experimental pain.
Dextromethorphan is used in non-prescription cough syrups. Naloxone is used for reversing the effects of narcotic pain relievers. Fentanyl is a narcotic used to treat pain and to make a person relaxed (sedated) before anesthesia. The purpose of this study is to see what kinds of pain are affected by these drugs in persons who have irritable bowel syndrome and persons who do not have this problem.
Conditions
- Irritable Bowel Syndrome
Interventions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-10-31
- Completion
- 2006-03-31
Countries
- United States
Study Locations
More Related Trials
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
NCT00101725 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01340053 ·Status: COMPLETED ·Phase: PHASE2
-
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
NCT04043455 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Diarrhea Predominant Irritable Bowel Syndrome in Females
NCT00461526 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT01887002 ·Status: TERMINATED ·Phase: PHASE2
-
Understanding Abdominal Pain in IBD and IBS
NCT04020835 ·Status: UNKNOWN
-
Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients
NCT00925223 ·Status: UNKNOWN
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome
NCT00486876 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
NCT03931785 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
NCT00139672 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Rifaximin With NAC in IBS-D
NCT06727422 ·Status: RECRUITING ·Phase: PHASE2
-
Vagal Nerve Stimulation in Irritable Bowel Syndrome
NCT06090110 ·Status: RECRUITING ·Phase: NA
-
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid
NCT01449487 ·Status: COMPLETED ·Phase: PHASE1
-
Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT02423421 ·Status: UNKNOWN ·Phase: PHASE2
-
Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine
NCT00880594 ·Status: TERMINATED ·Phase: NA
-
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
NCT01641341 ·Status: COMPLETED ·Phase: PHASE4
-
Mesotherapy Treatment of Irritable Bowel Syndrome
NCT06261320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
NCT06153420 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Functional Bowel Disorders
NCT00006157 ·Status: COMPLETED ·Phase: PHASE3
-
Fructose and Fructans in Irritabla Bowel Syndrome
NCT01776853 ·Status: COMPLETED ·Phase: NA
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA